Purple Biotech
PPBT
12 hedge funds and large institutions have $311K invested in Purple Biotech in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 3 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
258% more call options, than puts
Call options by funds: $261K | Put options by funds: $73K
0% more funds holding
Funds holding: 12 → 12 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
82% less capital invested
Capital invested by funds: $1.77M → $311K (-$1.46M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$41.3K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$35.9K |
| 3 |
Morgan Stanley
New York
|
+$26.9K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$7.79K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$7.19K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.07M |
| 2 |
Renaissance Technologies
New York
|
-$198K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$105K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$38.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Group One Trading
Chicago,
Illinois
| $65K | +$2.99K | +5 | +4% |
|
|
2
Morgan Stanley
New York
| $40K | +$26.9K | +45 | +115% |
|
|
WTB
3
Washington Trust Bank
Spokane,
Washington
| $39K | – | – | – |
|
|
VF
4
Virtu Financial
New York
| $33K | +$41.3K | +69 | New |
|
|
VVP
5
Venture Visionary Partners
Sylvania,
Ohio
| $31.2K | +$5.99K | +10 | +18% |
|
6
Geode Capital Management
Boston,
Massachusetts
| $30K | – | – | – |
|
|
7
Citadel Advisors
Miami,
Florida
| $28K | +$35.9K | +60 | New |
|
|
8
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $27K | -$38.9K | -65 | -53% |
|
|
9
UBS Group
Zurich,
Switzerland
| $11K | +$7.79K | +13 | +130% |
|
|
10
Simplex Trading
Chicago,
Illinois
| $5K | +$7.19K | +12 | New |
|
|
IA
11
IFP Advisors
Tampa,
Florida
| $1K | – | – | – |
|
|
NSIM
12
North Star Investment Management
Chicago,
Illinois
| $1K | – | – | – |
|
|
13
Point72 Asset Management
Stamford,
Connecticut
| – | -$1.07M | -1,357 | Closed |
|
|
14
Renaissance Technologies
New York
| – | -$198K | -251 | Closed |
|
|
SM
15
Sabby Management
Miami Beach,
Florida
| – | -$105K | -133 | Closed |
|
PPBT Hedge Fund Activity: Q2 2022 in Review
12 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Purple Biotech (PPBT) for Q2 2022, worth a combined $311K — down 82% from $1.77M a quarter earlier.
Fund positioning in PPBT was balanced in Q2 2022: 3 funds opened new positions, 3 closed out, 4 added to existing stakes and 1 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $41.3K. The largest seller was Point72 Asset Management, exiting entirely with an estimated $1.07M sold.
- 12 institutional investors held Purple Biotech (PPBT) as of Q2 2022, unchanged from Q1 2022.
- Funds reported $311K of Purple Biotech stock for Q2 2022, down 82% quarter-over-quarter.
- 3 funds opened new Purple Biotech positions in Q2 2022 and 3 closed out, a net change of 0 holders.
- The largest Purple Biotech buyer in Q2 2022 was Virtu Financial, an estimated $41.3K added.
- The largest Purple Biotech seller in Q2 2022 was Point72 Asset Management, an estimated $1.07M sold.
Based on aggregated 13F filings for Q2 2022.